Top Markets
Coin of the day
CardioGenics Holdings Inc CardioGenics Holdings Inc

CardioGenics Holdings Inc

CGNH
Rangering i aksjer #41819
CardioGenics Holdings Inc. focuses on the creation and global distribution of... CardioGenics Holdings Inc. focuses on the creation and global distribution of diagnostic testing solutions within the in vitro diagnostics (IVD) sector, serving markets across the United States, Canada, Europe, and other international regions. A key offering is the QL Care Analyzer, an automated, self-contained, and portable point-of-care (POC) immunoassay device. This analyzer utilizes a unique, patented self-metering cartridge to perform immunoassay evaluations directly at the point of care. The company also provides a range of immunoassay panels specifically engineered to detect cardiac biomarkers in blood, which is vital for identifying heart attacks. Additionally, CardioGenics supplies paramagnetic beads, serving as crucial solid supports in heterogeneous immunoassay procedures for both clinical and research institutions. Established in 1997, the company was initially known as Jag Media Holdings, Inc. before officially changing its name to CardioGenics Holdings Inc. in 2009. Its corporate headquarters are situated in Mississauga, Canada.
Aksjekurs
$0.0001
Sist synkronisert: 2026-08-11
Markedsverdi
$9.61K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
CA
Handel CardioGenics Holdings Inc (CGNH)

Kategori

Inntekter for CardioGenics Holdings Inc (CGNH)
Inntekter i 2026 TTM: 0
Ifølge CardioGenics Holdings Inc sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for CardioGenics Holdings Inc fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$7.61B -
US
$4.76B -
US
- -
CN
$1.42B -
US
$-252.70M -
US